Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2010
04/20/2010US7700363 Crystallization of protein solution in micro-chambers; Sreening protein crystal propagation; provide microarray, expose to protein crystal sample to support, monitor protein crystal growth or protein precipitation in wells
04/20/2010US7700362 Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain
04/20/2010US7700361 Secretory or membrane protein expressed in skeletal muscles
04/20/2010US7700360 Optical method and system to determine distribution of lipid particles in a sample
04/20/2010US7700359 Gene products differentially expressed in cancerous cells
04/20/2010US7700354 Rapidly screening for primitive hematopoietic cells; for use in transplantation and regenerative medicine; tissue engineering
04/20/2010US7700348 Comprises substrate presenting reflecting main surface with localized sites (containing halogen, silane, or silanol groups) which are sensitive to fluorescence detection by transparent layer; microarrays; improved fluorescence
04/20/2010US7700346 Tissue characteristic determination apparatus
04/20/2010US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
04/20/2010US7700334 immobilization with control over the orientation of the attachment; efficient, not requiring the previous purification of the protein to be attached, and can be activated by UV-light; photolithography
04/20/2010US7700323 Method for detecting and amplifying target DNA
04/20/2010US7700316 CD109 nucleic acid molecules, polypeptides and methods of use
04/20/2010US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders
04/20/2010US7700310 Method for detecting transferase enzymatic activity
04/20/2010US7700309 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau
04/20/2010US7700308 Methods for determining susceptibility to dental caries
04/20/2010US7700307 Mitochondrial stress-70 protein markers for colorectal cancer
04/20/2010US7700306 characterising a polypeptide by matrix assisted laser desorption ionization (MALDI) mass spectrometry; improving sensitivity, and can increase the number of peptides that are detected from a protein
04/20/2010US7700305 Analyte detection
04/20/2010US7700304 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening
04/20/2010US7700303 Biosensors, method for obtaining the same and uses thereof
04/20/2010US7700302 Method for generating and selecting antibodies against target protein
04/20/2010US7700301 Using protein tyrosine phosphatase (SHP-2) as tool in identifying compounds which modulate the activity of programed death-1 (PD-1); treating autoimmune, nervous system, tumor and immunosuppressive disorders
04/20/2010US7700300 Screening of compounds for GAT2 transporter activity
04/20/2010US7700299 predicting the response to a treatment with a HER inhibitor, preferably a HER dimerization inhibitor, in a patient comprising the steps of assessing a marker gene or a combination of marker genes; predicting the response of a metastatic breast cancer patient to treatment with pertuzumab
04/20/2010US7700298 Partitioning of label substance between solid and liquid phase; determination; immunoassay; incubation sample; binding; immobilization; using fluorescence or chemiluminescence labels; separation
04/20/2010US7700297 Artery- and vein-specific proteins and uses therefor
04/20/2010US7700296 Kit comprising monoclonal antibodies directed against an epitope; determining level in serum for diagnosis of coronary atherosclerosis, vascular calcification, angiogenesis, diabetes
04/20/2010US7700295 Elemental analysis of tagged biologically active materials
04/20/2010US7700294 Method of isolating cytotoxic heterocomplex associated with multiple sclerosis
04/20/2010US7700280 Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer
04/20/2010US7700276 pulsing blood cells present in the whole blood sample of step with an identical/similar and/or different immunomodulatory agent as present in the subject using a device or kit; diagnosis/prognosis/monitoring of a clinical status affecting the immune system
04/20/2010US7700275 Detection system
04/20/2010US7700274 Compositions and methods in cancer associated with altered expression of KCNJ9
04/20/2010US7700272 Ligand gated chloride channel for use as screening tool in identifying/screening pesticidal and antiparasitic agents
04/20/2010US7700271 Method of diagnosis and treatment and agents useful for same
04/20/2010US7700117 Camp factor of Streptococcus uberis
04/20/2010US7700114 original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, contain a deletion resulting in the production of a truncated non-functional protein; capable of enhancing the immunogenicity
04/20/2010US7700108 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker
04/20/2010US7700106 Therapeutic agent for ulcerative colitis
04/20/2010US7700104 Attenuated Salmonella SP12 mutants as antigen carriers
04/20/2010US7700101 modulating lipid levels and/or bone mass; diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis; bone disorders; Paget's disease
04/20/2010US7700088 Interleukin-9 mutein peptides
04/20/2010US7699969 Using multicompartment device to screen pharmaceutical compounds and manipulate particles utilizing dielectrophoretic forces; diagnostic assay for agrifood analysis
04/20/2010US7699967 Analysis implement with opening in insulation film
04/20/2010US7699966 Point of care heparin determination system
04/20/2010US7698929 High throughput screening methods for lubricating oil compositions
04/20/2010CA2640748C Methods for the diagnosis of dementia and other neurological disorders
04/20/2010CA2432363C Methods and reagents for the rapid and efficient isolation of circulating cancer cells
04/20/2010CA2407484C Reservoir monitoring
04/20/2010CA2405387C High-precision method and apparatus for evaluating creep damage
04/20/2010CA2394948C Screen-printable paste for producing a porous polymer membrane for a biosensor
04/20/2010CA2373389C Container having corner support
04/20/2010CA2329476C Ready-to-use ristocetin cofactor test reagent possessing long-term stability
04/20/2010CA2318486C Novel nucleic acid molecules correlated with the rhesus weak d phenotype
04/20/2010CA2219876C Stable variant hk2 polypeptide
04/20/2010CA2212702C Mucosal vascular addressins and uses thereof
04/20/2010CA2191884C Novel glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma
04/20/2010CA2134756C Selectin variants
04/17/2010CA2682439A1 Cell monitoring and molecular analysis
04/16/2010CA2683226A1 Diagnostic method and prognostic tool for osteoarthritis
04/15/2010WO2010042922A1 Correlating push force and stalk vibration to a plant's susceptibility to root lodging
04/15/2010WO2010042921A1 Gpcr arrestin assays
04/15/2010WO2010042903A1 Use and identification of biomarkers for gastrointestinal diseases
04/15/2010WO2010042852A2 T-cell-based identification of tissue antigens
04/15/2010WO2010042815A2 Vhh antibody fragments for use in the detection and treatment of cancer
04/15/2010WO2010042745A1 Biocompatible and photocurable polymers
04/15/2010WO2010042744A1 Microfluidic devices for reliable on-chip incubation of droplets in delay lines
04/15/2010WO2010042730A1 Methods for measuring the magnitude of attention and motor activity disturbance in a subject
04/15/2010WO2010042691A1 Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl)
04/15/2010WO2010042669A2 Co-culture compositions and methods
04/15/2010WO2010042637A2 Bead incubation and washing on a droplet actuator
04/15/2010WO2010042582A1 Hybrid preconcentrator for detection of materials
04/15/2010WO2010042538A1 Diagnosis and treatment of back pain
04/15/2010WO2010042525A1 Ovarian cancer biomarkers and uses thereof
04/15/2010WO2010042520A1 Methods of characterizing breast cancer and identifying treatments for same
04/15/2010WO2010042514A1 Nanopore and carbon nanotube based dna sequencer and a serial recognition elements
04/15/2010WO2010042456A1 Coffee refractometer method and apparatus
04/15/2010WO2010042435A1 Method of forming an auto-calibration circuit or label
04/15/2010WO2010042425A2 Detection of hiv-related proteins in urine
04/15/2010WO2010042284A2 Microfluidic control systems
04/15/2010WO2010042244A1 Pet scanning determination of lymph nodes enriched in 1241 labeled antibodies for cancer
04/15/2010WO2010042242A1 Methods and related devices for continuous sensing utilizing magnetic beads
04/15/2010WO2010042225A2 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides
04/15/2010WO2010042178A2 Cavity enhanced trace gas detection gradiometer
04/15/2010WO2010042070A1 Bio-assay using liquid crystals
04/15/2010WO2010042031A1 Semi-sequential assay for detection of an analyte in a sample
04/15/2010WO2010041971A1 Method for determination of delta-d values of non- exchangeable hydrogen stable isotopes on ethanol' s methyl group by means of irms instrumental technique
04/15/2010WO2010041875A2 Ultra high speed and high sensitivity base sequence analysis system and analysis method for same
04/15/2010WO2010041865A2 Method and kit for semen diagnosis through colour changes in methylene blue and semen quality evaluation using same
04/15/2010WO2010041805A1 Sensing device
04/15/2010WO2010041755A1 METHOD FOR MEASURING SURVIVIN mRNA
04/15/2010WO2010041736A1 Assay method using surface plasmon
04/15/2010WO2010041715A1 Novel fructosyl peptide oxidase
04/15/2010WO2010041595A1 Physiologically active substance measurement system
04/15/2010WO2010041439A1 Blood sample analysis method, blood sample analysis apparatus, and program
04/15/2010WO2010041423A1 Histopathologic diagnosis support system, histopathologic diagnosis support program, and histopathologic diagnosis support method
04/15/2010WO2010041390A1 Elastic wave sensor and detection method using the elastic wave sensor
04/15/2010WO2010041349A1 Marker for estimating the prognosis of cervical adenocarcinoma or for estimating the prognosis of cervical cancer
04/15/2010WO2010041231A2 Cell sorting device